Stay updated on Nivolumab in Hodgkin's Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in Hodgkin's Lymphoma Clinical Trial page.

Latest updates to the Nivolumab in Hodgkin's Lymphoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page's Locations section was updated to include additional sites across the US, Canada, and the UK. The revision note shows version 3.3.3.SummaryDifference1%

- Check19 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedPublications section now states that items are automatically filled from PubMed and may not be about the study. A revision tag was updated to Revision: v3.3.2, replacing the previous Revision: v3.2.0.SummaryDifference0.1%

- Check48 days agoChange Detected- Removed the lapse in government funding notice banner from the page. The banner previously warned that information may not be up to date due to funding issues.SummaryDifference0.3%

- Check62 days agoChange DetectedThe Study Details page shows only minor formatting and presentation updates; the core study information, including eligibility criteria and primary outcomes, remains unchanged.SummaryDifference0.3%

- Check91 days agoChange DetectedCore content updated: a government funding and operating status notice has been added and the version updated to v3.2.0; the prior v3.1.0 tag was removed.SummaryDifference2%

- Check98 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.0%

Stay in the know with updates to Nivolumab in Hodgkin's Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in Hodgkin's Lymphoma Clinical Trial page.